Try GOLD - Free

The Era Of Individualisation Has Only Just Begun

Express Pharma

|

September 16-30, 2018

For todays generation of digital natives, the ability to personalise the products they buy is increasingly expected as a given. To keep pace, the makers of these products need highly flexible manufacturing systems that are at the same time efficient and profitable. This introduces a whole new set of demands on plant infrastructure. An insight by Carmen Klingler-Deiseroth, a freelance journalist

The Era Of Individualisation Has Only Just Begun

THE VARIETY of options available for customising mass-produced products continues to grow. It’s no longer limited to the usual suspects like breakfast cereals, cars and photo books. Particularly among the younger generation of digital natives, there is a growing desire to fine-tune every online purchase to match their individual tastes and preferences. “The era of individualisation has only just begun,” declares Robert Kickinger, Mechatronic Technologies Manager, B&R.

Profitable production in batches of one Batch-size-one production is nothing new, really. In fact, it’s standard practice in many craft businesses. “What is new, however, is the idea of making customised products under mass-production conditions,” asserts Kickinger. So far, this has proven difficult to implement in a way that is economically viable. That’s because any increase in system flexibility is usually accompanied by a reduction in overall equipment effectiveness (OEE). “When that happens, individualisation is no longer profitable.”

The goal of mass customisation is therefore to keep the three factors of OEE – availability, performance and quality – at a level consistent with what can be achieved in mass production. In addition, manufacturers seek to maximise their return on investment (ROI) and to minimise their time to market (TTM) for new and improved products. “This is the only way to make mass customisation viable from an economic perspective.”

MORE STORIES FROM Express Pharma

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Translate

Share

-
+

Change font size